期刊文献+

反相高效液相色谱法测定犬血浆中甲硝唑浓度 被引量:2

Determination of metronidazole concentration in dog plasma by RP-HPLC
暂未订购
导出
摘要 目的建立犬血浆中甲硝唑浓度反相高效液相色谱(RP-HPLC)测定方法。方法采用反相高效液相色谱法C18柱,以0.05mol/L的KH2PO4(用1mol/L的磷酸调节pH3.5)∶乙腈∶甲醇(130∶35∶35,V/V/V)作为流动相,流速0.6ml/min,检测波长317nm,柱温25℃,内标为替硝唑。结果RP-HPLC测定甲硝唑血药浓度的线性范围是0.2-20.0μg/ml(r2=0.9986),定量下限为0.2μg/ml,准确度在85%-115%范围内,其日内、日间精密度≤15%。结论本法可用于甲硝唑犬体内药动学研究的需要,并成功地用于口服甲硝唑片剂后犬体内的药动学研究。 Objective To establish a RP-HPLC methood for determining the plasma concentration of metronidazole in dog. Methods A RP-HPLC method was developed. A column of C18 was used, with 0.05 mol/L KH2PO4 : acetonitrile: methnol( 130:35:35, V/V/V) as a mobile phase. The flow rate was 0.6 ml/min. The detective wavelength was set at 317 nm,and the column temperature was 25 ℃. Tinidazole was used as internal standard(IS). Results The calibration curve was linear over the concentration range of 0.2 - 20.0 μg/ml. Lower limit of quantification(LLOQ) was 0.2μg/ml, and the accuracy of metronidazole was 85 % - 115 %. The precision RSD was less than 15 %. Conclusion The RP-HPLC is validated to guarantee a reliable determination of metronidazole concentration in dog plasma. The method can be applied to investigate the pharmacokinetics profile of metronidazole in dogs after oral administration.
出处 《山西医科大学学报》 CAS 2008年第12期1109-1111,共3页 Journal of Shanxi Medical University
基金 山西省资助回国留学人员科研基金资助项目(2005029) 太原市科技明星专项基金资助项目(07020425) 山西医科大学青年基金资助项目(2006)
关键词 甲硝唑 反相高效液相色谱法 血药浓度 metronidazole RP-HPLC plasma concentration of drug
  • 相关文献

参考文献5

二级参考文献17

  • 1[1]MJ Galmier,AM Frasey,M Bastide,et al. Simple and sensitive method for determination of metronidazole in human serum by HPLC[J]. Chromatogr,1998,720:239-243.
  • 2[3]Talwar Naresh,Jain NK HPLC determination of metronidazole in tablets and biological samples[J].Indian Drugs,1991,29(2):78.
  • 3刘剑刚.替硝唑、交沙霉素及其联用对5种厌氧菌的最低抑菌浓度试验.中国医院药学杂志,2000,20(8):507-507.
  • 4Chow A W,Patten V,Gouze LB.Susceptibility of anaerobic bacteria to metronidazole: Relative resistance of non- spore-forming gram positive bacilli[J].J Infecrt Dis,1975,131:182.
  • 5Brogden RN,Heel RC,Speight TM,et al.Metronidazole in anaerobic infections:a review of its activity[J].Pharmacokinet Ther Drugs,1978, 16:387-417.
  • 6Crowell AL,Sanders-Lewis KA,Secor WE.In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of trichomonas vaginalis[J].Anti microb Agents Chemother,2003, 47:1407-1409.
  • 7Krishnaiah YS,Bhaskar RPR,Satyanarayana V,et al.Studies on the development of oral colon targeted drug delivery systems for metronidazole in the treatment of amoebiasis[J].Int J Pharmaceutics,2002,236:43-55.
  • 8Rajnarayana K,Chaluvadi MR,Alapati VR,et al.Validated HPLC method for the determination of tinidazole in human serum and its application in a clinical pharmacokinetic study[J].Pharmazie,2002, 57:535-537.
  • 9Jessa MJ,Barret DA,Shaw PN,et al.Rapid and selective high -performance liquid chromatographic method for the determination of metro -nidazole and its active metabolite in human plasma,saliva and gastric juice[J].J Chromatogr,1996, 67:374-379.
  • 10卢云,石景森,卓健生.胆囊结石病人胆汁中厌氧菌检测及药敏分析[J].中国实用外科杂志,1998,18(10):604-606. 被引量:21

共引文献15

同被引文献30

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部